Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3280305rdf:typepubmed:Citationlld:pubmed
pubmed-article:3280305lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3280305lifeskim:mentionsumls-concept:C0006949lld:lifeskim
pubmed-article:3280305lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:3280305lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:3280305pubmed:issue2lld:pubmed
pubmed-article:3280305pubmed:dateCreated1988-4-28lld:pubmed
pubmed-article:3280305pubmed:abstractTextHepatotoxic reactions in patients receiving carbamazepine (CBZ) therapy have been reported, and some have been considered fatal. We present two patients with hepatic dysfunction secondary to CBZ therapy. Liver biopsies were compatible with hepatotoxic damage, and the symptoms were reversible with medication withdrawal. Our patients are representative of those in the literature, most of whom have granulomatous hepatitis and sometimes have associated cholangitis. The patients with fatal reactions differed clinically and pathologically from the others, and may represent a different entity. The clinical syndrome resembles a viral hepatitis. Elderly patients seem to be particularly susceptible and their hepatic function should be monitored closely when CBZ therapy is initiated.lld:pubmed
pubmed-article:3280305pubmed:languageenglld:pubmed
pubmed-article:3280305pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3280305pubmed:citationSubsetIMlld:pubmed
pubmed-article:3280305pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3280305pubmed:statusMEDLINElld:pubmed
pubmed-article:3280305pubmed:issn0013-9580lld:pubmed
pubmed-article:3280305pubmed:authorpubmed-author:HorowitzSSlld:pubmed
pubmed-article:3280305pubmed:authorpubmed-author:MarcusEElld:pubmed
pubmed-article:3280305pubmed:authorpubmed-author:PatwardhanRRlld:pubmed
pubmed-article:3280305pubmed:issnTypePrintlld:pubmed
pubmed-article:3280305pubmed:volume29lld:pubmed
pubmed-article:3280305pubmed:ownerNLMlld:pubmed
pubmed-article:3280305pubmed:authorsCompleteYlld:pubmed
pubmed-article:3280305pubmed:pagination149-54lld:pubmed
pubmed-article:3280305pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:meshHeadingpubmed-meshheading:3280305-...lld:pubmed
pubmed-article:3280305pubmed:articleTitleHepatotoxic reactions associated with carbamazepine therapy.lld:pubmed
pubmed-article:3280305pubmed:affiliationDepartment of Neurology, St. Vincents Hospital, University of Massachusetts Medical School, Worcester 01604.lld:pubmed
pubmed-article:3280305pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3280305pubmed:publicationTypeReviewlld:pubmed
pubmed-article:3280305pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280305lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3280305lld:pubmed